QUOTE AND NEWS
Business Wire  Feb 8  Comment 
Synovis Life Technologies, Inc. (Nasdaq: SYNO), has received Food and Drug Administration 510(k) marketing clearance for its Flow Coupler®, an innovative extension of the company’s well-established Microvascular Anastomotic Coupler used in several
Business Wire  Jan 5  Comment 
Synovis Life Technologies, Inc. (Nasdaq: SYNO), a leading biomaterial and surgical products company, announced today that its wholly owned subsidiary, Synovis Micro Companies Alliance, Inc. (Synovis MCA), has received exclusive worldwide distribution
StreetInsider.com  Dec 2  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Synovis+Life+%28SYNO%29+Posts+In-Line+Non-GAAP+Q3+EPS+of+5c/5152010.html for the full story.
Business Wire  Dec 2  Comment 
Synovis Life Technologies, Inc. (NASDAQ: SYNO), today reported strong revenue performance for the fourth fiscal quarter and full fiscal year ended Oct. 31, 2009. For the 2009 fiscal fourth quarter, net revenue rose to $15.0 million, an 18 percent
Business Wire  Nov 30  Comment 
Synovis Life Technologies, Inc. (Nasdaq: SYNO), a leading biomaterial and surgical products company, announced today that The American Journal of Surgery has published an article on the performance of Synovis’ Veritas® Collagen Matrix for the
Business Wire  Nov 24  Comment 
Synovis Life Technologies, Inc. (Nasdaq: SYNO), announced today that it has hired Patrick L. Horan to fill the key role of vice president of sales for the Surgical Group. Richard W. Kramp, president and chief executive officer, said, “We are
Business Wire  Nov 16  Comment 
Synovis Life Technologies, Inc., (NASDAQ: SYNO) will host a live webcast of its fiscal fourth-quarter and full-year conference call on Wednesday, Dec. 2, 2009, at 10 a.m. CT. Synovis President and Chief Executive Officer Richard Kramp and Chief



Thank you for your suggestion


 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki